According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -A$19.74 M. In 2023 the company made an earning of A$17.62 M an increase over its 2022 earnings that were of -A$17.8 M.The earnings displayed on this page is the company's Pretax Income.